Skip to main content
Erschienen in: Virchows Archiv 1/2024

04.11.2023 | ORIGINAL ARTICLE

Erythrophagocytosis is not a reproducible finding in liver biopsies, and is not associated with clinical diagnosis of hemophagocytic lymphohistiocytosis

verfasst von: Niyati Desai, Satoru Kudose, Helen E. Remotti, Armando Del Portillo, Ladan Fazlollahi, Michael J. Lee, Yuqing Xiong, Roger K. Moreira, Marcela Salomao, Maria Isabel Fiel, Raul S. Gonzalez, Joseph Misdraji, Ryan M. Gill, John Hart, David E. Kleiner, Uta Drebber, Andrew M. Bellizzi, Stephen M. Lagana

Erschienen in: Virchows Archiv | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare disease with high mortality. Liver involvement is common (based on elevated liver function tests) with most patients demonstrating acute hepatitis. Liver biopsies are frequently obtained in the setting of suspected HLH for the purpose of identification of erythrophagocytosis, and if present, this finding is thought to suggest or support the diagnosis of HLH. However, there are problems with this approach; in particular, we do not know whether this finding is reproducible or whether it is specific to HLH. Therefore, we conducted a multi-institutional study in which experienced liver pathologists reviewed images taken from liver biopsies from patients with normal liver, acute hepatitis, possible HLH, and clinical HLH to determine if there was agreement about the presence or absence of erythrophagocytosis, and to ascertain whether the finding corresponds to a clinical diagnosis of HLH. Twelve liver pathologists reviewed 141 images in isolation (i.e., no clinical information or diagnosis provided). These came from 32 patients (five normal, 17 acute hepatitis, six HLH, four possible HLH). The pathologists classified each image as negative, equivocal, or positive for erythrophagocytosis. Kappa was .08 (no agreement) for case-level and 0.1 for image-level (1.4% agreement, based on two images which were universally considered negative). There was no difference in the proportion of pathologists who diagnosed erythrophagocytosis among those with different diagnoses at case or image-level (p = 0.82 and p = 0.82, respectively). Thus, erythrophagocytosis is an entirely unreliable histologic parameter in liver, as it is irreproducible and not demonstrably associated with a clinical disease (namely, HLH). Unless and until more reliable guidelines can be established, pathologists should refrain from commenting on the presence or absence of erythrophagocytosis in liver biopsy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18(1):29–33PubMed Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18(1):29–33PubMed
18.
Zurück zum Zitat (2017) R: a language and environment for statistical computing. Author: R Core Team Organization: R foundation for statistical computing. Location: Vienna, Austria. Year. url: https://www.R-project.org/ (2017) R: a language and environment for statistical computing. Author: R Core Team Organization: R foundation for statistical computing. Location: Vienna, Austria. Year. url: https://​www.​R-project.​org/​
20.
Zurück zum Zitat Desai N, Del Portillo A, Fazlollahi L, Lee MJ, Remotti HE, Kudose S, Lagana SM (2023) Hemophagocytosis (or Pseudohemophagocytosis) is questionably reproducible in liver biopsy but is common in cases of acute hepatitis without clinical hemophagocytic lymphohistiocytosis. Liver Pathology. Laboratory Investigation 103(3). https://doi.org/10.1016/j.labinv.2023.100095 Desai N, Del Portillo A, Fazlollahi L, Lee MJ, Remotti HE, Kudose S, Lagana SM (2023) Hemophagocytosis (or Pseudohemophagocytosis) is questionably reproducible in liver biopsy but is common in cases of acute hepatitis without clinical hemophagocytic lymphohistiocytosis. Liver Pathology. Laboratory Investigation 103(3). https://​doi.​org/​10.​1016/​j.​labinv.​2023.​100095
23.
Zurück zum Zitat Tsuda H, Yoshida M, Akiyama F, Ohi Y, Kinowaki K, Kumaki N, Kondo Y, Saito A, Sasaki E, Nishimura R, Fujii S, Homma K, Horii R, Murata Y, Itami M, Kajita S, Kato H, Kurosumi M, Sakatani T, Shimizu S, Taniguchi K, Tamiya S, Nakamura H, Kanbayashi C, Shien T, Iwata H (2021) Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study. Jpn J Clin Oncol 51(3):434–443. https://doi.org/10.1093/jjco/hyaa235CrossRefPubMed Tsuda H, Yoshida M, Akiyama F, Ohi Y, Kinowaki K, Kumaki N, Kondo Y, Saito A, Sasaki E, Nishimura R, Fujii S, Homma K, Horii R, Murata Y, Itami M, Kajita S, Kato H, Kurosumi M, Sakatani T, Shimizu S, Taniguchi K, Tamiya S, Nakamura H, Kanbayashi C, Shien T, Iwata H (2021) Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study. Jpn J Clin Oncol 51(3):434–443. https://​doi.​org/​10.​1093/​jjco/​hyaa235CrossRefPubMed
25.
Zurück zum Zitat Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR (2008) Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett’s esophagus biopsies. Am J Gastroenterol 103(9):2333–40. https://doi.org/10.1111/j.1572-0241.2008.02020.x. (quiz 2341)CrossRefPubMed Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR (2008) Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett’s esophagus biopsies. Am J Gastroenterol 103(9):2333–40. https://​doi.​org/​10.​1111/​j.​1572-0241.​2008.​02020.​x. (quiz 2341)CrossRefPubMed
26.
Zurück zum Zitat Alpert L, Setia N, Ko HM, Lagana SM, Pittman ME, Johncilla M, Drage MG, Zhao L, Salomao MA, Liao X, Choi WT, Jenkins SM, Hart J, Harpaz N, Voltaggio L, Lauwers GY, Odze R, Remotti H, Smyrk TC, Graham RP (2021) Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologists. Virchows Arch 478(6):1061–1069. https://doi.org/10.1007/s00428-020-02998-zCrossRefPubMed Alpert L, Setia N, Ko HM, Lagana SM, Pittman ME, Johncilla M, Drage MG, Zhao L, Salomao MA, Liao X, Choi WT, Jenkins SM, Hart J, Harpaz N, Voltaggio L, Lauwers GY, Odze R, Remotti H, Smyrk TC, Graham RP (2021) Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologists. Virchows Arch 478(6):1061–1069. https://​doi.​org/​10.​1007/​s00428-020-02998-zCrossRefPubMed
Metadaten
Titel
Erythrophagocytosis is not a reproducible finding in liver biopsies, and is not associated with clinical diagnosis of hemophagocytic lymphohistiocytosis
verfasst von
Niyati Desai
Satoru Kudose
Helen E. Remotti
Armando Del Portillo
Ladan Fazlollahi
Michael J. Lee
Yuqing Xiong
Roger K. Moreira
Marcela Salomao
Maria Isabel Fiel
Raul S. Gonzalez
Joseph Misdraji
Ryan M. Gill
John Hart
David E. Kleiner
Uta Drebber
Andrew M. Bellizzi
Stephen M. Lagana
Publikationsdatum
04.11.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2024
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-023-03683-7

Weitere Artikel der Ausgabe 1/2024

Virchows Archiv 1/2024 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …